Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Jan 14, 2026-- Fresenius Kabi, an operating company of Fresenius, and TQ Therapeutics, announced today they have entered into a strategic-development agreement under which Fresenius Kabi has an exclusive license to …